BRIEF-Valeant's former CEO may remain as consultant through 2017
May 31 (Reuters) - Valeant Pharmaceuticals International Inc
* Under separation agreement with former CEO pearson, he will provide consulting services to company through december 31, 2017
* Pearson will receive $83,333 for each month during consulting period that services are performed through end of 2016
* Pearson will receive $15,000 for each month that services are performed for remainder of consulting period
* Former CEO Pearson entitled to receive pro-rated annual bonus in respect of 2016 fiscal year and severance payment equal to $9 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2016 All rights reserved.